Genomenon Mastermind alternative · for oncology product / engineering teams shipping clinical software
Genomenon Mastermind alternative for oncology reporting and CDS workflows
UNMIRI · See the NGS Interpretation API
Mastermind is best-of-class at one specific verb: find the literature evidence for a variant. 11M+ full-text articles, 3.7M+ supplemental tables, peer-reviewed methodology, and a decade of indexing depth. For a lab scientist doing ACMG classification or a curator hunting precedent in published literature, Mastermind is the answer.
That's a different job from what UNMIRI does. UNMIRI Engine 1 + Engine 2 pick up where literature search ends: produce a tier-classified, AMP/ASCO/CAP-mapped, citation-grounded report block that drops into your EHR, LIS, or oncology decision-support tool via a documented API. Different shape, different buyer.
At a glance
| Dimension | Genomenon Mastermind | UNMIRI |
|---|---|---|
| Primary verb | Search and review variant literature | Render normalized FHIR Genomics output from a vendor NGS report (Engine 1) + emit CDS alerts (Engine 2) |
| Buyer | Variant scientists, lab directors, curators; some biopharma medical affairs (custom Genomic Landscapes) | Product / engineering at EHR vendors, digital pathology platforms, oncology decision support tools |
| Output shape | Search UI with evidence cards per variant; PRO API returns curated annotations | FHIR Genomics R4 Bundle: variants + biomarkers + CDx flags + trial matches, deterministic templates |
| Knowledge moat | Curated literature corpus + CKB (acquired from Jackson Lab, 2024) | Open clinical evidence (CIViC CC0, ClinVar, ClinicalTrials.gov, openFDA, CPIC); customer-verifiable |
| Pricing | CORE free (limited gene set, ad-supported), PRO low-thousands per seat, Genomic Landscape custom six-figure projects | $30-150K ACV mid-market, $250-750K top-tier EHR/pathology platforms |
| Integration | Web app + Mastermind Automation API (PRO tier) | API-first; the FHIR Genomics output is the deliverable, no UI required for downstream integration |
Often complementary, not competitive
Many serious clinical-genomics product teams might use both at different layers of their stack: Mastermind for hand-curated evidence depth on individual variants, UNMIRI for the cross-vendor parsing + structured ingestion + report-rendering layer. UNMIRI's schema includes an evidence.externalLevelsextension hook for licensed implementations (OncoKB, COSMIC, Mastermind's curated layer) to plug in under their own licensing terms.
We're not arguing against Mastermind's corpus depth. We're arguing that the report-rendering and CDS-emission jobs are different jobs, and they want a different tool than a search engine.
When Genomenon Mastermind is the right pick
- Your workflow is literature evidence per variant: you want the deepest, most recent corpus and you'll do the classification yourself.
- Your team includes curators or variant scientists doing ACMG/AMP classification work where Mastermind's supplemental-table extraction matters.
- You're at a biopharma running a rare-disease or oncology pipeline that needs a custom Genomic Landscape engagement — that's where Mastermind's six-figure curation projects live.
- You don't need an EHR-ready FHIR Genomics output; the evidence is the output.
When UNMIRI is the right pick
- You're shipping clinical software (EHR, digital pathology, oncology CDS) and you need a normalized data contract, not a search UI.
- You receive vendor NGS reports (Foundation Medicine, Tempus, Caris, Guardant, Natera) and need to ingest them as structured FHIR resources, not as PDFs.
- You want open clinical evidence sources your customers can verify on the source's own site (CIViC, ClinVar, openFDA). License-clean for downstream sharing.
- Your end product is a clinical decision support alert or an EHR-integrated report, not an annotated evidence card.
Frequently asked questions
- Does UNMIRI curate variant evidence like Mastermind?
- No. UNMIRI cites open public sources (CIViC, ClinVar, ClinicalTrials.gov, openFDA, CPIC) that customers can verify on the source's own site. Curation depth comparable to Mastermind's hand-vetted corpus is not part of UNMIRI's offering.
- Can our team use Mastermind alongside UNMIRI?
- Yes. Many do. Mastermind handles the variant-literature-search job; UNMIRI handles the parsing + structured output + CDS-rendering job. The evidence.externalLevels schema field is the hook for plugging in Mastermind's curated annotations under your own license.
- What's the right comparison if I'm buying for variant scientists, not product engineers?
- Mastermind is the right tool for variant scientists doing ACMG/AMP classification. UNMIRI is the wrong tool for that workflow. UNMIRI's buyer is the team shipping clinical software that consumes vendor NGS reports as input.
- Why open evidence sources instead of curated content?
- Audit-defensibility. A health-system informatics team doing CDS due diligence can pull the source on the source's own site and confirm. Closed-curation products don't allow this, which slows compliance review.
Talk to us about Engine 1 + Engine 2
Inspect the open FHIR Genomics schema first to see what UNMIRI's output actually looks like. Then book time.